Adding to the body of knowledge about bowel cancer
The contribution of medical research towards reducing the impact of bowel cancer cannot be underestimated.
Research improves understanding of the disease and drives evidence-based prevention, detection and management strategies.
Supporting medical research is therefore an important aspect of Bowel Cancer Australia's mission.
Bowel Cancer Australia has demonstrated its ongoing commitment to current medical research through annual project grants. These have included:
- a national survey of colonoscopy quality and training
- a study of bowel cancer rates and outcomes in young people
- an investigation into the communication of bowel cancer risk and the need for screening in first degree relatives
- laboratory research into how different bowel cancer cell lines respond to chemotherapy.
Bowel Cancer Research Grant Applications
In 2013, Bowel Cancer Australia joined with Federal Government agency, Cancer Australia and other major cancer charities to improve funding for bowel cancer research.
The Priority-driven Collaborative Cancer Research Scheme (PdCCRS) is an annual national research project grants scheme which funds cancer research in identified priority areas to help reduce the impact of cancer in the community and improve outcomes for people affected by cancer.
The scheme aims to:
- coordinate funding of priority-driven cancer research at the national level;
- foster collaboration between cancer researchers to build Australia's cancer research capacity; and
- foster consumer participation in cancer research, from design to implementation.
Applicants requesting PdCCRS grant funding from Bowel Cancer Australia are advised that at least one of the following Bowel Cancer Australia research priorities must be addressed in their application:
- Research into prevention and/or early diagnosis of bowel cancer;
- Research addressing the social and public health needs of all individuals, and their families, living with a diagnosis of bowel cancer. This also includes under-served populations such as people aged less than 50 years;
- Research addressing all aspects of advanced bowel cancer;
- Research encompassing translational research, with the potential to deliver outcomes that are clinically relevant or otherwise ready to be implemented to facilitate prevention or to improve the care of those with bowel cancer;
- Multidisciplinary bowel cancer research, which encourages research across disciplines and academic boundaries;
- Research into novel health service delivery for bowel cancer.
Grant applications ranging from one to three years within a budget ranging from $10,000 to $200,000 per annum will be considered by Cancer Australia and Bowel Cancer Australia.
Project grants of up to three years duration, with funding available up to $600,000 (GST-exclusive), with a maximum in any one year of approximately $200,000 (GST-exclusive) will be offered by Bowel Cancer Australia. All project grant applications ranging from 1 to 3 years within a budget ranging from $10,000 to approximately $200,000 per annum will be considered by Cancer Australia and these funding partners.
These research projects must be:
- Priority-driven (relate specifically to a research priority area specified by Cancer Australia and/or Bowel Cancer Australia).
- Outcome/impact focused (projects will improve outcomes in cancer control and/or impact on populations with poorer outcomes within the community).
- Translatable (approaches and methodologies will be provided to translate research findings to impact on clinical practice, policy and/ or further research in order to impact on cancer control in Australia).
- Collaborative (projects are cross-disciplinary, national, multi-state, multi-institutional and/or key disciplines are part of the grant application).
- Engage consumers (consumers are involved in the design and ongoing conduct of the research project).